Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Pharmacoepidemiology 2020

About Conference


We heartily welcome to all participants around the globe to participate in conference titled “ 12th  International Conference on Clinical Research and Pharmacoepidemiology” which is scheduled to happen on September 28-29, 2020 in Abu Dhabi, UAE.This global event is going to be a great opportunit for participants who willing to gather knowledge as well as experience in the field of pharmacy and clinical resrach.

The global conference of 2019 on Pharmacoepidemiology was the multidisciplinary one and event was  far-reaching to cooperates along with individuals from across the world concentrated on  findings of epidemiology, pharmacology and clinical researches.This upcoming 2020 stage event is your excellent chance to realize Earth's biggest get-together of delegates across from Pharmacists clinical scientists, medicinal officers and gatherings  social workers, related affiliations, drug specialist, government officers and businessesleaders.It explains superb service given by the pharmacists who had done the great job to increase pharmaceutical and medication care for marketing of health care and disease prevention.

It has given a promising history of upgrading the practices through new approaches and innovations. Clinical Pharmacy is more of a patient-cantered discipline. The Clinical pharmacy field is not restricted to any certain specific area but has reach out towards other medical fields which includes Cardiology, Nephrology ,Oncology internal medicine and many more.

Reasons to attend:

  • The presentation along with keynote is going to be excited among scientific community.
  • The certificates and award are which recognise your profession in research and health.
  • Awards are given to the budding young researcher ,investigators and to young scientists
  • Through the attending conference you can reach research network and marketing resources.
  • In the global community you can connect to stakeholders and Global Pharma leaders.
  • The participants from the Pharma community can give their poster presentation, workshop.

 

Why to Attend: 12th International Conference on Pharmacoepidemiology and Clinical Research is happening during on September 28-29, 2020 in Abu Dhabi, UAE which is making an event aiming to bring closer exposer to leading academic from across the globe. They are professors, scientists, researchers and students to discus and share their valuable experiences and research results on all concepts of Pharmacoepidemiology, Clinical reserach. It also gives a premier expertise pathway on Pharma, Regulatory, Drug Designing and clinical trial industries to showcase their technological innovations and share the most recent approaches, trends, and knowledge as well as practical challenges encountered and solutions taken in the fields of Pharmacoepidemiology & Clinical research.

Pharmaceutical research gives a valuable business opportunity to more pharmaceutical and biotech companies as these technologies have wide application areas such as drug discovery and research followed by new drugdelivery systems. Pharmacoepidemiology is the study which deals with utilization and study of drugs in large numbers of people and it present an estimate of the probability of beneficial effects of a drug in group of people and tchance of adverse effects.

Pharmacoepidemiology study specialise on clinical patient from therapeutics by using test of clinicalepidemiology and understand to know the influence of beneficial and adverse drug effects of genetic change in drug reaction and clinical drug interactions and the effects of medication. Pharmacovigilance is branch of pharmacoepidemiology in continual monitoring on community for undesirable effects and other safety steps rising drugs which arein market. Pharmacoepidemiology sometimes also involves the conduct and improving of programmatic efforts to enhances medication use on a population basis. 

1. The detailed epidemiology explains disease and exposure may consist of calculating rates incidence prevalence  Kind of descriptive studies do not use health control groups and can only generate theory but not on test them. It Studies of drug use mainly fall under category of descriptive studies.

2.  Epidemiology analytics consist of two types of studies: The observational studies consist of case-control and cohort studies and experimental studies which had clinical trials or randomized clinical trials. The investigative studies compare an exposed community with a control group and usually made as hypothesis testing by studies.

Pharmacoepidemiology and Clinical research :Congress consist of a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and Business to Business interactions.

Mark your calendar dates to meet the expert’s, leaders connect the critical discussions  at Pharmacoepidemology and Clinical Research Congress scheduled during September 28-29, 2020 in Abu Dhabi, UAE. Register now to unleash Advanced Clinical research and compliance in Pharmacoepidemology field.

Why Should Attend??

  • The conference assembles with eminent speakers showing the most current advances in the field, connected differing qualities in each sense.We likewise integrated talks on most recent innovation for concentrating   on biological inquiries.
  • The conference shows on the wider aspect of the scientific contribution to showcase the new scientific and technical advances in comparison to the ancient theories. Your context to our visualization together will set a platform for the exchange of ideas towards contribution to advanced innovation.
  • We encourage multidisciplinary approach as well. Not only speaker presentations but also workshops and exhbition networking opportunities are available. A different Opportunity for Advertisers and Sponsors at this International event.

Who Should Attend??

  • Medical advisors
  • Hospitals and associations
  • Biotech and Medical Device industries/Pharma
  • Clinical research sites  
  • CROs and CMOs
  • Clinical Research & Development
  • Clinical Design/ Protocol Design/ Clinical Strategy
  • Global Clinical Operations
  • Clinical Outsourcing
  • Biostatistics/Data management
  • Patient Recruitment/Enrolment
  • Clinical Trial Management
  • clinical Trial Supplies
  • Regulatory Affairs
  • PhD Scholars
  • Graduates and post graduates in industrial pharmacy
  • Scholars from Pharmaceutical backgrounds
  • Distributors and Suppliers of Drug Delivery Technologies
  • Graduates and post graduates in industrial pharmacy
  • Business Development Managers
  • Researchers, Professors, Students, and Faculty of Pharmaceutical Sciences from Universities and Medical Colleges

 

 

Sessions/Tracks

Track 1: Molecular Pharmacoepidemiology

It is the study of drugs effect on Human and clinical pharmacology is the study of effect of drugs on clinical humans. Part of the task of clinical pharmacology is to provide a risk benefit assessment by effects of drugs in patients.It mainly focuses on genetics and clinical effects and uses this data on observational and experimental methods to evaluate the effectiveness and safety of drug treatment on the population.It is useful in clinical problems in molecular pharmacoepidemiology by thinking about the mechanism by which genes can effects drug response. Medications with a narrow therapeutic are good targets for the use in the molecular pharmacoepidemiology to improve the use and application of medications.There are many problem comes in the methodology like screening.

Track 2: Clinical pharmacology and Therapeutic

It is the study of drugs in humans and study of adverse effects on the human case.The basic science of pharmacology mainly focus on uses of pharmacological principles and methods in the laboratory setting in the study of biomarkers, pharmacokinetics, drug metabolism and genetics .clinical trials includes pharmacokinetics which are again divided into absorption,dissolution ,metabolism and excretion.It deals with how the movement of a drug in the body until it excrete from our body. Drug metabolism is the breakdown of drugs by the metabolic process which happen in the living organisms.The enzymes are responsible for the breaking the drugs.The study of drug metabolism is also called pharmacokinetics.

Track 3: Pharmacokinetics and Pharmacogenomics

It is the study of how genes affect a person’s response to drugs in the pharmacology and genomics to develop effective,safe medications and doses of particular medicine is altered to a person’s genetic makeup.It may difficult to predict who will get benefit from a medication,who will not respond at all,and who will experience negative side effects.The nagtiveside effects is aslo called Adverse drug reactions which have significantcasuse of hospitalizations and deaths in the world pharmacogenomics:It is the study of how genes affect a person's response to drugs. The response of drugs depends on the genome of DNA.

Track 4: Neuropharmacology

It is the study of how drugs targets cellular function in the nervous system and reaction to behaviour. There are two main branches of neuropharmacology:behavioural and molecular.Behavioural neuropharmacology deals with focuses on the study of how drugs affect human behavioural is the study of how drug dependence and addiction affect the human brain.Molecular neuropharmacology involves the study of neurons and their neurochemical interactions of developing drugs that have beneficial effects on neurological function.The bioactive compound are phenylethanoid glycoside. Cistanches Herba extracts and its related compounds help as a cure for Alzheimer's disease and Parkinson's disease.It provides guidance for further research on the clinical application of Cistanches Herba.

Track 5: Psychotropic Medicine

They are the kind of medicine which effects the thinking of mind, emotions,feeling and behaviour of a person. Psychology is the study of mind and brain. The psychological knowledge is often applied to treatment of health problem .In the olden days the problem related to the brain and mental health is very serious,their were many scientists worked on the psychotropic medicine.The first psychotropic drug was used as thorazine.It is used for treating with people who effecting from depression, anxiety, calmness etc.The psychotropic drugs are aripiprazole, asenapine,which are used as the anti anxiety and antidepression does.

Track 6: Cardiovascular Pharmacology

cardiovascular pharmacology is the study which deals with of the effects of drugs and the smooth muscle in the vessel wall, altering its diameter and accordingly directing the volume of blood stream.There are some drugs which effect the cardiovascular system.The anticoagulants are used for stopping the clotting of the blood and angiotensin are used in vasoconstriction increase in the blood pressure Side effects of anticoagulants are bleeding of the skin.The Side effects of angiotensin cough, elevated blood potassium levels, low blood pressure  headache, drowsinessand rash.Hypertension is disorder associated with increased risk of stroke, heart failure, and chronic renal failure.Thiazide diuretics, calcium channel blockers these are the agents used for the hypertension.

Track 7: Nursing and Anesthesia Pharmacology

It is the study of reaction of certain drug, chemical and reactions of medication on the patient or people .Nursing anesthesia is generally used at  the time of surgery.These are drugs used to cause complete or partial loss of sensation.General aesthetics can cause central nervous system depression to produce loss of pain sensation and consciousness.Where has local anaesthetics cause the same sensation and feeling in certain parts of the body without producing the systemic effects related to severe CNS depression.Nursing anesthesai is again divided into General and local anethesia.General anaesthetic drugs are ketamine,ketalar,midazolam,propanol.Local anaesthetic drugs are Benzocaine ,Procain ,chloroprocain, lanacain .

Track 8: Immunopharmacology

 It is study of pharmacology that deals with drugs acting on the immune system and along with the pharmacological actions of substances which are acting on the immune system.The adaptive divisions of the immune system are critical to the maintenance of homeostasis,physical integrity, and health.Intricately interactive pathways of cells are cell surface receptors, antibodies and cytokines provide surveillance against invasive pathogens and nonself entities and internal destruction and removal of host senescent cells.The specificity and efficacy of these immune components interacting with their respective ligands provide the mechanistic basis of immune function.Several disease conditions occur upon immune dysfunction including immune deficiency, allergy ,rash.

Track 9: Cancer Pharmacoepidemiology and Genomic

It uses the methods to study the benefits and risks of drug therapy in clinical and people. In the field of cancer, pharmacoepidemiology  gives  the effects of medications on cancer risk patient  disease prevention,and response to treatments, adverse or the long-term effects of chemotherapeutic and other pharmacologic agents which are  used to treat cancer people.Genomics is the study of genes which are acting on the person when medication is given to person understanding how variability in genes encoding for drug-metabolizing enzymes,drug transporters, drug receptors and proteins involved in pathway signaling influences individual differences in adverse effects and treatment efficacy and effectiveness.Development to approval of new target.

Track 10: Hospital Pharmacy and Industrial Pharmacy

It is a specialized field of pharmacy that is integrated into care of a medical centre.These medical centre are hospital, outpatient clinic, drug, poison control centre, drug information centre of residential care facility.The Industrial Pharmacy is a kind of discipline which includes manufacturing, development, marketing and distribution of drug including quality assurance of these activities.It is an important component of health care systems around the world.The hospital pharmacy gives the information about drug reacts and effects on the area of resident.Hospital hospital pharmacy gives an important role in the industries related to the clinical research and the drug discovery

Track 11: Regulatory Affairs & Utilization Research

It is a kind of profession  that meets  desire of governments to protect public health by controlling the safety and efficacy of health  products in areas including pharmaceuticals, veterinary medicines, medical devices  pesticides, agrochemicals cosmetics and complementary medicines from the companies.Regulatory affairs officers ensure that products such as cosmetics,pharmaceuticals,and veterinary medicines meet legislative requirements.The important duties of a RA is studying scientific and legal documents gathering information on evaluating, organising in a variety of formats in the company.

Track 12: Drug safety

 It is the main aspect of medical therapy that can play a major role in deciding which drug should be given to a patient.Pharmacovigilance is also known as study of drug safety.It is refers to collecting,maintaining and checking the data collected from clinical trails.These measures of drug safety gives the information about Utilization in the research field.He is the person who study safety and efficacy of the drugs in the clinical research.He responsible for the reporting the drug reaction during the drug therapy.His information is applied in the research and in the clinical trials.

Track 13: Clinical Data Management

 clinical data manegment are responsible for collecting data from a wide variety of medical research projects such as clinical and pharmaceutical trials.They will work in collaborate to make sure data is collected, managed and reported clearly, accurately and securely. Medical data refers to health-related information that is associated with regular patient care or as part of a clinical trial program.This includes electronic health records, which are digital versions of a person's medical information. Clinical data analyst is a professional person who verifies and gives the information about  validity of scientific experiments and gathered data from research.The main purpose of these data analytics is to verify that processes and protocols are followed, improving the quality and efficiency of patient care.

Track 14:Reporting adverse drug reactions

 In pharmacology adverse drug reaction are the unexpected or dangerous reaction to a drug when a person took drug a single dosageform.An unwanted effect caused by the administration of a drug is called as adverse reactions of drugs.The onset of the adverse reaction may be sudden or it depends on the over time of drugs.The reactions of reporting adverse happens in the clinical trails or in the hospitals.The failure to reporting the adverse drugs reaction mayleads to the causalities,death to the person.Adverse drugs reporting helps in the improvement of drug design in industry, clinical trails in the research field  .

 Track 15: Drug design

 In general drug design is the design of molecules that are complementary in shape and they are charge to the biomolecular target with which they interact and binds to it. The drug design helps to find the different kind of dosage forms .It will helps in the targeting at  binding site which ions , protein ,atoms interact  at target site .Rational drug design is a  process used in the biopharmaceutical industry to discover and develop new drug compounds. It uses a variety of computational methods to identify novel compounds, design compounds for selectivity, efficacy and safety, and develop compounds into clinical trial candidates .The drug design depends on the structure and the target.

 

Market Analysis

 Pharmaceutical industry:

From Middle-East to North Africa consists of 18 countries from Morocco to Iran. This region had gradually developed its Pharma market to more than 140 companies are operating in this region. MENA {middle east and north Africa} pharmaceutical market accounts approximately 2% of the world market.

The pharmaceutical sector in the Middle-East and North Africa has observed remarkable growth in the region over the last few years and is estimated to grow around US$60 billion by 2025, with US$1.2-billion allocated for the healthcare system in the 2019 budget.The governments in this region had focusing more and more on the well-being of a growing population and enhancing healthcare services, timely and safe delivery of medical supplies and pharmaceuticals products has laid down the promising future for pharmaceutical industry in the region of middle east.According to globe Pharma studies, the pharmaceutical sector’s growth in the region is largely driven by high population growth and it has increased life expectancy and the good lifestyle.

The global pharmaceutical market was worth $934.8 billion in 2017and will reach $1,170 billion in 2021, growing at around 5.8%.The Middle East and North Africa is the region is noted for quick expansion of the pharmaceutical sector.According to the some research the Pharmaceutical market has reached to $25B in value in 2018, with a short-term growth of 13% from 2017 to 2018.This speed growth of market is forecasted to grow to $60B by 2025.The growth in the pharmaceutical sector in this region is mainly attributed to change in population dynamics,where the population is changing, but also ageing.The rapid growth in the economy from oil production and tourism had led to a good and sedentary lifestyle which is the main source of increase in various non-contagious chronic illnesses.

 

pharmaceutical revenue in Billions:

  1. In 2016 it is 36 billions
  2. In 2017 it was 33.34 billions
  3. In 2018 it has 25 billions
  4. In 2019 it had 30 billions
  5. In 2020 it will be into 40 billions

Clinical Research:

The clinical research industry of  Abu Dhabi gives the Services  on clinical trial and the service providers which are used to offer a high quality,cost-effective service and clinical expertise to the hospitals, and the healthcare units.The clinical laboratory  reports of UAE, services market, analyses the current and gives future prospects of the market.The clinical reports  gives the information about the test types, and its segments market opportunity analysis along with a market snapshot and comparative analysis.This report provides in-depth analysis of the clinical laboratory services market in Abu Dhabi.The responsible person  for giving  report include laboratories ,pharmaceutical.The diagnostic companies providing clinical test solutions and laboratory services .The market analysis gives a test types and service providers makes significant segments in the UAE market in 2016.The clinical laboratories  are those players in the Clinical laboratories service.The middle east clinical trials market size was estimated at USD 1.36 billion in 2019 and expected to expand to 1.95 USD in 2024  at a  CAGR of 7.55% over the forecast period.

Upgrading of new technology in clinical trials increasing prevalence of chronic diseases, and demand from developing countries are some of the major factors running the global market.Where as rising demand for Contract Research Organizations for conduct clinical trials is projected to further runs the growth.The talented expertise of CROs as compared to pharma companies when it comes to performing clinical trials in wide array of geographies and development of drugs in specific therapeutic areas and  these are the  factors responsible for the demand for CROs in pharmaceutical segment.On the BioOutsource Report 2017,the demand for bio similar testing is expected witness growth in U.S. attributed to the fact that the Food and Drug Administration  has started addressing the lack of clear guidance with regards to biosimilars, specifically the way the developers should prove similarity of their drugs to that of the originator product.

 

Scope of Pharmacoepidemiology in Middle East:

The recent advance in the technology and the increase in population size has made a bright future of clinical and pharmacoepiodiomolgy in the Middle East region.The government of Abu Dhabi has made changes in the governing polices which results in the more outcome of people in the region. The lifestyle of people had changed with the facility from the government.The cases for the rate for all strokes ranged between 22.7 and 250 per 100,000 people per year.The growth rate for stroke ranged comes in 508 and 777 per 100,000 population.Among reporting studies gender differences75% reported a high male-to-female ratio are stroke patients.The actual age of stroke was within the sixth and the seventh decade.Blood clotting or the heart stroke was reported more numbers times followed by intracerebral haemorrhage and subarachnoid haemorrhage.Rise in blood pressure was the common reported risk factor followed by diabetes.The reports of case-fatality rate within one month was 12–32. During the last ten years,there was rise in stroke incidence and mortality rates in the Middle East.This region going through rates of self-awareness and control of noncommunicable diseases and also lacks knowledge for stroke risk factors, awareness, causes, and symptoms.

 Associations of Pharmaceutical Societies across the Globe:

  • International Pharmaceutical Federation (FIP)
  • International Pharmaceutical Students' Federation (IPSF)
  • European Association of Employed Community Pharmacists in Europe (EPhEU)
  • Pharmaceutical Group of the European Union (PGEU)
  • Australian College of Pharmacy
  • Pharmaceutical Society of Australia
  • The Pharmacy Guild of Australia
  • The Society of Hospital Pharmacists of Australia
  • Canadian Pharmacists Association
  • Canadian Society of Hospital Pharmacist
  • Ontario Pharmacists Association
  • Chinese Pharmaceutical Association
  • Danish Association of Pharmaconomists
  • Pharmaceutical Society of Ireland
  • The Pharmaceutical Association of Israel
  • Kuwait Pharmaceutical Association

Related societies

From Europe:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of Neuropsychopharmacology;  European Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research UnitDrug Information Association: Society of ToxicologySociety of Environmental Toxicology and ChemistryEuropean Industrial Pharmacists GroupEuropean Pharmaceutical Students AssociationPharmaceutical Group of the European UnionEuropean Association of Hospital PharmacistsEuropean Confederation of Pharmaceutical EntrepreneursEuropean Generic Medicines AssociationEuropean Federation of Pharmaceutical Industries and Associations .

From Middle Eeast :

Scientific Centre of Drug and Medical Technology ExpertiseNational Health Regulatory AuthorityMinistry of Health - Pharmaceutical ServicesEgyptian Drug AuthorityGeorgia Drugs and Narcotics AgencyJordan Food and Drug AdministrationKuwait Drug and Food Control AdministrationPharmacy and Drug ControlJapan Society of Drug Delivery SystemOral Drug Delivery Focus GroupInhalation Drug Delivery Association-IDDAThe Pharmaceutical and Novel Drug Delivery Healthcare Sciences Society (PHSS); Drug Information AssociationPharmaceutical Group of European Union (PGEU); Applied Pharmaceutical Nanotechnology Society (APN); Controlled Release Society (CRS); Congress on Innovation in Drug Delivery (APGI); International Society for Aerosols in Medicine (ISAM)

From Asia:

Chinese Pharmaceutical AssociationIndian Pharmacist AssociationPakistan Pharmacists AssociationJapan Pharmaceutical Manufacturers AssociationAssociation of Pharmacy ProfessionalsPharmaceutical Association of MauritiusThe Pharmaceutical Association of IsraelKuwait Pharmaceutical AssociationDrug Office - Department of HealthPharmaceuticals and Medical Devices AgencyMinistry of Food and Drug SafetyDirectorate General of Drug AdministrationCentral Drugs Standard Control OrganizationNational Agency of Drug and Food ControlNational Pharmaceutical Control Bureau.

From USA:

New York Health Products CouncilPharmaceutical Research and Manufacturers of AmericaAmerican Association of Colleges of Pharmacy;  American Society of Health-System PharmacistaProfessional Compounding Centers of AmericaCanadian Pharmacists AssociationAmerican Society of Health-System Pharmacists; Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness; 

Past Conference Report

We honestly thank all our wonderful Keynote and Plenary Speakers, Conference Attendees, Students, Media Partners and Pharmaceutical Associates for making Pharmacoepidiemology 2019 a grand success.

The 12th International Conference on Clinical research and pharmacoepidiemology hosted by Middle East Conferences which was held during November 18-19, 2019 Abu Dhabi, UAE.  Theme based on the “Broaden the possibilities for Policy, Education, and Advocacy in the field of Pharmacoepidemology and Clinical Research". Compassionate response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from the field of Pharmaceutical Chemistry, Chemistry and Analytical science, who made this event a magnificent success.

Middle East Conferences would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Pharmacoepidemology 2019:

  • Christopher Tirotta, Director Cardiac Anesthesia, USA.
  • Geoffroy Lumay, Associate professor - Soft Matter Physics chair, Belgium.                                  
  • Pasharawipas Tirasak, Professor in Medical Science Department, Thailand.                 
  • Pierre A. Morgan MRGN Advisor, Switzerland.                                                               
  • Harish Rajak, Assistant Professor of Pharmaceutical Medicinal Chemistry, India.                  

Middle East Conferences offers its grateful appreciation on organizations such as our respected Media Partners, Exhibitors, and other eminent leaders who supported the conference by promoting in various modes online and offline which helped the conference reach every stage and corner of the globe. It also took privilege to compliment the Keynote Speakers, Organizing Committee Members, and Chairs who supported this event.

With grand success of Pharmacoepidiemology 2019, we are proud to announce conference “12thInternational Conference on Pharmacoepidiemology and Clinical research" to be held during September 28-29, 2020 at Abu Dhabi, UAE.

Let us meet again @ Pharmacoepidiemology 2020

To Collaborate Scientific Professionals around the World

Conference Date September 28-29, 2020

Speaker Opportunity

Past Conference Report

Supported By

Advances in Pharmacoepidemiology and Drug Safety Journal of Clinical Trials Journal of Clinical Research & Bioethics

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by